loading
전일 마감가:
$9.39
열려 있는:
$9.43
하루 거래량:
1.86M
Relative Volume:
1.15
시가총액:
$2.96B
수익:
$2.68B
순이익/손실:
$-184.45M
주가수익비율:
-13.89
EPS:
-0.6805
순현금흐름:
$229.23M
1주 성능:
+10.66%
1개월 성능:
+14.27%
6개월 성능:
+22.25%
1년 성능:
+19.47%
1일 변동 폭
Value
$9.335
$9.59
1주일 범위
Value
$8.50
$9.59
52주 변동 폭
Value
$6.685
$9.59

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
명칭
Amneal Pharmaceuticals Inc
Name
전화
908-947-3120
Name
주소
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
직원
5,210
Name
트위터
@amnealpharma
Name
다음 수익 날짜
2025-05-02
Name
최신 SEC 제출 서류
Name
AMRX's Discussions on Twitter

AMRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
AMRX
Amneal Pharmaceuticals Inc
9.45 2.95B 2.68B -184.45M 229.23M -0.6805
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
154.11 67.83B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.00 46.74B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.65 43.52B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.86 20.12B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
313.13 14.11B 2.99B 1.21B 1.13B 25.06

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-06 개시 Goldman Buy
2025-02-24 업그레이드 JP Morgan Neutral → Overweight
2024-09-06 업그레이드 JP Morgan Underweight → Neutral
2021-04-07 재개 RBC Capital Mkts Sector Perform
2021-03-08 업그레이드 Goldman Sell → Buy
2020-12-14 업그레이드 Barclays Equal Weight → Overweight
2020-12-14 업그레이드 Guggenheim Neutral → Buy
2020-07-27 개시 Goldman Sell
2020-05-12 업그레이드 Guggenheim Sell → Neutral
2019-12-12 다운그레이드 Raymond James Outperform → Mkt Perform
2019-11-12 다운그레이드 JP Morgan Neutral → Underweight
2019-11-07 다운그레이드 SVB Leerink Outperform → Mkt Perform
2019-07-22 업그레이드 SVB Leerink Mkt Perform → Outperform
2019-07-11 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2019-07-08 업그레이드 Piper Jaffray Neutral → Overweight
2019-06-11 개시 Barclays Equal Weight
2019-05-21 업그레이드 Raymond James Mkt Perform → Strong Buy
2019-03-20 개시 SunTrust Buy
2019-03-08 다운그레이드 SVB Leerink Outperform → Mkt Perform
2018-12-14 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2018-10-16 다운그레이드 SunTrust Buy → Hold
2018-08-13 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2018-07-23 개시 Morgan Stanley Overweight
2018-06-22 개시 B. Riley FBR, Inc. Buy
모두보기

Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스

pulisher
Aug 15, 2025

Amneal Pharma EVP Shah sells $666k in shares By Investing.com - Investing.com Nigeria

Aug 15, 2025
pulisher
Aug 15, 2025

Can Amneal Pharmaceuticals Inc. expand into new marketsWeekly Investment Report & Weekly Stock Breakout Alerts - kangso.co.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Amneal Pharmaceuticals stock hits 52-week high at 9.48 USD By Investing.com - Investing.com Australia

Aug 15, 2025
pulisher
Aug 14, 2025

Wall Street Analysts See a 27.66% Upside in Amneal (AMRX): Can the Stock Really Move This High? - Yahoo Finance

Aug 14, 2025
pulisher
Aug 13, 2025

Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know - TradingView

Aug 13, 2025
pulisher
Aug 13, 2025

Amneal Will End Sale of Calcium-Drip Copies in Patent-Suit Pact - Bloomberg Law News

Aug 13, 2025
pulisher
Aug 13, 2025

Amneal Pharmaceuticals Insider Sold Shares Worth $302,596, According to a Recent SEC Filing - MarketScreener

Aug 13, 2025
pulisher
Aug 13, 2025

Here's Why Momentum in Amneal (AMRX) Should Keep going - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

AMRX Q2 Deep Dive: New Product Launches and Specialty Momentum Shape Guidance - ca.finance.yahoo.com

Aug 13, 2025
pulisher
Aug 12, 2025

Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know - TradingView

Aug 12, 2025
pulisher
Aug 12, 2025

Is Amneal Pharmaceuticals Inc. forming a bullish divergenceGuaranteed Profit Setup Watchlist - newsyoung.net

Aug 12, 2025
pulisher
Aug 11, 2025

Truist Financial Maintains a Buy on Amneal Pharmaceuticals (AMRX) With an $8 PT - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

Brown Rudnick Represents Amneal Pharmaceuticals LLC in a $2.1 Billion Term Loan Credit Facility - Brown Rudnick

Aug 11, 2025
pulisher
Aug 11, 2025

‘Made-In-America’ Amneal Does Not Fear Trump’s Proposed ‘Chaotic’ Triple-Digit Tariffs On Drugs - insights.citeline.com

Aug 11, 2025
pulisher
Aug 11, 2025

Amneal Pharmaceuticals Inc. Stock Poised for Technical ComebackRisk Controlled Picks With Real Returns Outlined - beatles.ru

Aug 11, 2025
pulisher
Aug 10, 2025

Published on: 2025-08-11 02:04:05 - metal.it

Aug 10, 2025
pulisher
Aug 10, 2025

Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate - MSN

Aug 10, 2025
pulisher
Aug 10, 2025

Published on: 2025-08-10 19:02:24 - metal.it

Aug 10, 2025
pulisher
Aug 10, 2025

Earnings Beat: Amneal Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - ca.finance.yahoo.com

Aug 10, 2025
pulisher
Aug 08, 2025

Amneal 2025 Q2 Earnings Strong Performance as Net Income Surges 112% - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Amneal (AMRX) Q2 EPS Jumps 56% - AOL.com

Aug 08, 2025
pulisher
Aug 08, 2025

Results: Amneal Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st

Aug 08, 2025
pulisher
Aug 07, 2025

Amneal Pharma Reports Strong Q2 2025 Results - The Globe and Mail

Aug 07, 2025
pulisher
Aug 06, 2025

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025
pulisher
Aug 06, 2025

Amneal Pharmaceuticals Reports Strong Q2 2025 Results - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

Amneal Pharmaceuticals Q2 2025 Earnings: EPS Beats Estimates, Revenue Falls Short - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Amneal: Q2 Earnings Snapshot - New Haven Register

Aug 06, 2025
pulisher
Aug 06, 2025

Amneal Pharmaceuticals Inc (AMRX) Q2 2025 Earnings Call Highlights: Strong Growth and Raised ... By GuruFocus - Investing.com Canada

Aug 06, 2025
pulisher
Aug 05, 2025

Amneal Pharma’s Optimistic Q2 Earnings Call Highlights - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals' 2025Q2 Earnings Call: Key Contradictions on RYTARY, CREXONT, and Margin Strategies - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

AMNEAL PHARMACEUTICALS Q2 2025 Earnings Call Transcript - MarketBeat

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings call transcript: Amneal Pharma Q2 2025 EPS beats forecast - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings call transcript: Amneal Pharma Q2 2025 EPS beats forecast By Investing.com - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals Stock Rises Amid Growth Signals - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals shares rise 5.53% intraday after revising earnings guidance and raising fiscal 2025 outlook. - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Transcript : Amneal Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal (AMRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Raises Outlook Even As Revenue Falls Short - Finimize

Aug 05, 2025
pulisher
Aug 05, 2025

Knight Therapeutics Submits CREXONT Marketing Authorization Application in Mexico - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals Lifts Annual Earnings Outlook As Q2 Net Income Surges; Pre-Market Stock Up - Nasdaq

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals Surpasses Q2 Earnings ExpectationsNews and Statistics - IndexBox

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025 - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharma A earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals beats Q2 estimates, raises full-year outlook - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal (NASDAQ:AMRX) Misses Q2 Sales Targets - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings Flash (AMRX) Amneal Pharmaceuticals, Inc. Reports Q2 Revenue $724.5M, vs. FactSet Est of $744.6M - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals Reports Strong Q2 2025 Results and Raises Full Year Guidance Following Successful Debt Refinancing - Quiver Quantitative

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Reports Second Quarter 2025 Financial Results - GlobeNewswire

Aug 05, 2025
pulisher
Aug 05, 2025

Amneal Pharmaceuticals' Q2 revenue misses estimates - MarketScreener

Aug 05, 2025

Amneal Pharmaceuticals Inc (AMRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$29.05
price up icon 2.80%
$17.96
price down icon 0.22%
drug_manufacturers_specialty_generic RDY
$14.22
price up icon 0.78%
$10.61
price down icon 0.75%
$132.90
price up icon 1.21%
$313.13
price up icon 0.34%
자본화:     |  볼륨(24시간):